Profile for Costa Rica Patent: 10861
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Costa Rica Patent: 10861
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Aug 26, 2029 | Janssen Pharms | INVOKAMET XR | canagliflozin; metformin hydrochloride |
| ⤷ Start Trial | Aug 26, 2029 | Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride |
| ⤷ Start Trial | Aug 26, 2029 | Janssen Pharms | INVOKANA | canagliflozin |
| ⤷ Start Trial | Jun 3, 2028 | Janssen Pharms | INVOKAMET XR | canagliflozin; metformin hydrochloride |
| ⤷ Start Trial | Jun 3, 2028 | Janssen Pharms | INVOKAMET | canagliflozin; metformin hydrochloride |
| ⤷ Start Trial | Jun 3, 2028 | Janssen Pharms | INVOKANA | canagliflozin |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
